Refractory Angina Treatment Market is driven by Innovative...

ein Foto hinzugefügt Health

2025-05-02 10:43:14 -

Refractory Angina Treatment Market is driven by Innovative TherapeuticsNew Section

Refractory angina, characterized by chronic chest pain unresponsive to standard medical and revascularization therapies, affects a significant subset of ischemic heart disease patients. The market offers a spectrum of advanced interventions—including novel pharmacological agents (such as ivabradine and ranolazine), gene therapy vectors, cell-based regenerative treatments, enhanced...

0 Kommentare 0 Anteile 828 Ansichten 0 Vorschau